STEPHANIE PINCHERA: Open Payments
NPI 1699962563 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,236 in 50 payments from 22 companies in 2025. Trend: 2023 $103 · 2024 $43 · 2025 $1,236
Food & beverage: $1,236
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $151 |
| Novartis Pharmaceuticals Corporation | 5 | $109 |
| GENZYME CORPORATION | 1 | $106 |
| Abbott Laboratories | 1 | $100 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $89 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $81 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Impulse Dynamics (USA) Inc. | 2 | $51 |
Products named: REPATHA, AVEIR, Kerendia, JARDIANCE, LEQVIO, LifeVest, CAMZYOS, FARXIGA.
Industry payments across AZ — which companies pay providers there.
